DYNEX CAPITAL INC (DX)

US26817Q8868 - REIT

12.57  +0.14 (+1.13%)

After market: 12.56 -0.01 (-0.08%)

Fundamental Rating

3

Taking everything into account, DX scores 3 out of 10 in our fundamental rating. DX was compared to 64 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. Both the profitability and financial health of DX have multiple concerns. DX is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year DX has reported negative net income.
In the past year DX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DX reported negative net income in multiple years.
Each year in the past 5 years DX had a positive operating cash flow.

1.2 Ratios

DX has a Return On Assets of 1.02%. This is in the better half of the industry: DX outperforms 64.06% of its industry peers.
Looking at the Return On Equity, with a value of 6.95%, DX is in the better half of the industry, outperforming 64.06% of the companies in the same industry.
Industry RankSector Rank
ROA 1.02%
ROE 6.95%
ROIC N/A
ROA(3y)2.01%
ROA(5y)1.63%
ROE(3y)8.41%
ROE(5y)4.42%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of DX (26.41%) is better than 89.06% of its industry peers.
DX does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 26.41%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

DX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DX has more shares outstanding
DX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DX is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.91, we must say that DX is in the distress zone and has some risk of bankruptcy.
DX has a worse Altman-Z score (-0.91) than 89.06% of its industry peers.
DX has a debt to FCF ratio of 406.54. This is a negative value and a sign of low solvency as DX would need 406.54 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 406.54, DX is doing worse than 62.50% of the companies in the same industry.
DX has a Debt/Equity ratio of 5.63. This is a high value indicating a heavy dependency on external financing.
DX's Debt to Equity ratio of 5.63 is on the low side compared to the rest of the industry. DX is outperformed by 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.63
Debt/FCF 406.54
Altman-Z -0.91
ROIC/WACCN/A
WACC5%

2.3 Liquidity

DX has a Current Ratio of 0.05. This is a bad value and indicates that DX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.05, DX is not doing good in the industry: 82.81% of the companies in the same industry are doing better.
A Quick Ratio of 0.05 indicates that DX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.05, DX is doing worse than 82.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05

6

3. Growth

3.1 Past

The earnings per share for DX have decreased strongly by -11.76% in the last year.
DX shows a strong growth in Revenue. In the last year, the Revenue has grown by 225.49%.
The Revenue has been growing slightly by 3.79% on average over the past years.
EPS 1Y (TTM)-11.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.29%
Revenue 1Y (TTM)225.49%
Revenue growth 3Y11.17%
Revenue growth 5Y3.79%
Sales Q2Q%139.52%

3.2 Future

DX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.31% yearly.
DX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 147.95% yearly.
EPS Next Y42.27%
EPS Next 2Y61.13%
EPS Next 3Y43.31%
EPS Next 5YN/A
Revenue Next Year134.48%
Revenue Next 2Y211.41%
Revenue Next 3Y147.95%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DX. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 22.19, the valuation of DX can be described as rather expensive.
70.31% of the companies in the same industry are cheaper than DX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, DX is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 22.19

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, DX is valued a bit more expensive than the industry average as 65.63% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 91.19
EV/EBITDA N/A

4.3 Compensation for Growth

DX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DX's earnings are expected to grow with 43.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.13%
EPS Next 3Y43.31%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 14.48%, DX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 13.29, DX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, DX pays a better dividend.
Industry RankSector Rank
Dividend Yield 14.48%

5.2 History

The dividend of DX decreases each year by -8.86%.
DX has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of DX decreased in the last 3 years.
Dividend Growth(5Y)-8.86%
Div Incr Years0
Div Non Decr Years2

5.3 Sustainability

DX pays out 134.84% of its income as dividend. This is not a sustainable payout ratio.
DP134.84%
EPS Next 2Y61.13%
EPS Next 3Y43.31%

DYNEX CAPITAL INC

NYSE:DX (12/20/2024, 8:06:14 PM)

After market: 12.56 -0.01 (-0.08%)

12.57

+0.14 (+1.13%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)10-21 2024-10-21/bmo
Earnings (Next)01-27 2025-01-27/amc
Inst Owners53.95%
Inst Owner Change0.29%
Ins Owners1.19%
Ins Owner Change-1.22%
Market Cap1.44B
Analysts84
Price Target14.15 (12.57%)
Short Float %4.5%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield 14.48%
Dividend Growth(5Y)-8.86%
DP134.84%
Div Incr Years0
Div Non Decr Years2
Ex-Date01-02 2025-01-02 (0.15)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-103.71%
Min EPS beat(2)-246.74%
Max EPS beat(2)39.32%
EPS beat(4)1
Avg EPS beat(4)-115.65%
Min EPS beat(4)-246.74%
Max EPS beat(4)39.32%
EPS beat(8)1
Avg EPS beat(8)-245.64%
EPS beat(12)1
Avg EPS beat(12)-167.43%
EPS beat(16)3
Avg EPS beat(16)-125.58%
Revenue beat(2)1
Avg Revenue beat(2)28.99%
Min Revenue beat(2)-83.68%
Max Revenue beat(2)141.66%
Revenue beat(4)2
Avg Revenue beat(4)-168.94%
Min Revenue beat(4)-794.38%
Max Revenue beat(4)141.66%
Revenue beat(8)4
Avg Revenue beat(8)-68.8%
Revenue beat(12)5
Avg Revenue beat(12)-45.24%
Revenue beat(16)7
Avg Revenue beat(16)-33.47%
PT rev (1m)0.3%
PT rev (3m)2.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)95.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-66.41%
Revenue NQ rev (1m)2.13%
Revenue NQ rev (3m)1385.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-79.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.19
P/S 4.8
P/FCF 91.19
P/OCF 91.19
P/B 1.26
P/tB 1.26
EV/EBITDA N/A
EPS(TTM)-0.76
EYN/A
EPS(NY)0.57
Fwd EY4.51%
FCF(TTM)0.14
FCFY1.1%
OCF(TTM)0.14
OCFY1.1%
SpS2.62
BVpS9.96
TBVpS9.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.02%
ROE 6.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 26.41%
GM N/A
FCFM 5.26%
ROA(3y)2.01%
ROA(5y)1.63%
ROE(3y)8.41%
ROE(5y)4.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 5.63
Debt/FCF 406.54
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 19.92%
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -0.91
F-Score5
WACC5%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.29%
EPS Next Y42.27%
EPS Next 2Y61.13%
EPS Next 3Y43.31%
EPS Next 5YN/A
Revenue 1Y (TTM)225.49%
Revenue growth 3Y11.17%
Revenue growth 5Y3.79%
Sales Q2Q%139.52%
Revenue Next Year134.48%
Revenue Next 2Y211.41%
Revenue Next 3Y147.95%
Revenue Next 5YN/A
EBIT growth 1Y61.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-88.24%
FCF growth 3Y-29.03%
FCF growth 5Y-19.2%
OCF growth 1Y-88.24%
OCF growth 3Y-29.03%
OCF growth 5Y-19.2%